Sentinel Lymph Node Biopsy
Mostrando 37-48 de 53 artigos, teses e dissertações.
-
37. Sentinel lymph node biopsy: Sentinel node technique has drawbacks
BMJ Publishing Group Ltd..
-
38. Sentinel lymph node biopsy: Authors' reply
BMJ Publishing Group Ltd..
-
39. The sentinel node in breast cancer
Biopsy of the sentinel lymph node now forms part of routine management in many centres dealing with early stage breast cancer. This article seeks to discuss developments over the past number of years and to summarise current practice.
e-Med.
-
40. Sentinel lymph node biopsy: Optimum method remains to be determined
BMJ Publishing Group Ltd..
-
41. Sentinel lymph node biopsy: Not yet standard of care for melanoma
BMJ Publishing Group Ltd..
-
42. Therapeutic Effect of Sentinel Lymph Node Biopsy in Melanoma Remains an Open Question
American Society of Clinical Oncology.
-
43. Clinical practice guidelines for the care and treatment of breast cancer: 13. Sentinel lymph node biopsy
-
44. Sentinel lymph node biopsy: Is now an established and widely available technique for breast cancer and melanoma
BMJ Publishing Group Ltd..
-
45. Role of axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast
BioMed Central.
-
46. Sentinel lymph node biopsy in malignant melanoma
Is unnecessary as clinically important micrometastases can be identified by ultrasound
BMJ Publishing Group Ltd..
-
47. The orderly progression of melanoma nodal metastases.
OBJECTIVE. The aim of this study was to determine the order of melanoma nodal metastases. SUMMARY BACKGROUND DATA. Most solid tumors are thought to demonstrate a random nodal metastatic pattern. The incidence of skip nodal metastases precluded the use of sampling procedures of first station nodal basins to achieve adequate pathological staging. Malignant mel
-
48. Lessons learned from 500 cases of lymphatic mapping for breast cancer.
OBJECTIVE: To evaluate the factors affecting the identification and accuracy of the sentinel node in breast cancer in a single institutional experience. SUMMARY BACKGROUND DATA: Few of the many published feasibility studies of lymphatic mapping for breast cancer have adequate numbers to assess in detail the factors affecting failed and falsely negative mappi